| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Oct 26, 2021 | Sell(S) | 278 | $7.90 | $2K | 0 |
| Oct 25, 2021 | Grant(A) | 129 | $7.78 | $1K | 278 |
| Oct 18, 2021 | Grant(A) | 2K | $10.10 | $25K | 2K |
| Sep 29, 2021 | Grant(A) | 10 | $10.08 | $101 | 15 |
| Sep 28, 2021 | Grant(A) | 5 | $10.07 | $50 | 5 |
| Sep 28, 2021 | Grant(A) | 149 | $10.08 | $2K | 149 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-028917) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for SAB Biotherapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001493152-21-028917"
Use Arkolith to summarize insider buying and selling at SAB Biotherapeutics, Inc. over the last 90 days and cite the filings.